|
Back to Home » May 2012 News » Royalty Pharma Raises $600 Million of Debt |
Royalty Pharma Raises $600 Million of Debt |
May 25, 2012
NEW YORK, NY--(Marketwire - May 24, 2012) - Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust ("RPIFT"), bringing total debt outstanding at RPIFT to approximately $3.4 billion. Proceeds will be used to fund future acquisitions.
Source URL: http://www.marketwire.com/mw/release.do?id=1661595&sourceType=3
|
|
|
|
